...The company has European rights to ulipristal acetate to treat gynecological indications, excluding contraception, from HRA Pharma S.A....
...Allergan’s Ulipristal Acetate" ). Allergan plc (NYSE:AGN), Dublin, Ireland Gedeon Richter plc (Budapest:RICHTER), Budapest, Hungary HRA Pharma S.A....
...Fibristal - Canada) Business: Genitourinary Paul Bonanos EllaOne, Esmya, Fibristal, Ulipristal, ulipristal acetate (PGL4001, cdb-2914, ella) Gedeon Richter plc HRA Pharma S.A. Allergan...

...The company has European rights to ulipristal acetate to treat gynecological indications, excluding contraception, from HRA Pharma S.A....
...in Canada as Fibristal. Allergan plc (NYSE:AGN), Dublin, Ireland Gedeon Richter plc (Budapest:RICHTER), Budapest, Hungary HRA Pharma S.A....
...PGL4001) (formerly CDB-2914) Business: Genitourinary Alicia Parker EllaOne, Esmya, Fibristal, Ulipristal, ulipristal acetate (PGL4001, cdb-2914, ella) Gedeon Richter plc HRA Pharma S.A. Allergan...

...The company has European rights to ulipristal acetate to treat gynecological indications, excluding contraception, from HRA Pharma S.A....
...in Canada as Fibristal. Allergan plc (NYSE:AGN), Dublin, Ireland Gedeon Richter plc (Budapest:RICHTER), Budapest, Hungary HRA Pharma S.A....
...EU, Fibristal - Canada, Ella, ellaOne, PGL4001) (formerly CDB-2914) Business: Genitourinary Jaime De Leon Ella ellaOne Esmya Fibristal PGL4001 Ulipristal acetate Gedeon Richter plc HRA Pharma S.A. Allergan...

...The company has European rights to ulipristal acetate to treat gynecological indications, excluding contraception, from HRA Pharma...
...in Canada as Fibristal. Allergan plc (NYSE:AGN), Dublin, Ireland Gedeon Richter plc (Budapest:RICHTER), Budapest, Hungary HRA Pharma S.A....
...Activities subscale score and safety Status: Phase III data Milestone: Submit NDA (2H17) Jaime De Leon Esmya Fibristal Ulipristal acetate HRA Pharma S.A. Allergan...

...III study (see BioCentury Extra, May 9, 2016) . Gedeon has rights to ulipristal from HRA Pharma S.A....

...The company has European rights to ulipristal acetate to treat gynecological indications, excluding contraception, from HRA Pharma...
...in Canada as Fibristal. Allergan plc (NYSE:AGN), Dublin, Ireland Gedeon Richter Ltd. (Budapest:RICHTER), Budapest, Hungary HRA Pharma S.A....

...no treatment-related adverse events in the 157-patient study. Gedeon Richter has rights to ulipristal from HRA Pharma S.A....

...Gedeon Richter has European rights to ulipristal acetate to treat gynecological indications, excluding contraception, from HRA Pharma...
...American rights to the compound for benign gynecological disorders. Gedeon Richter Ltd. (Budapest:RICHTER), Budapest, Hungary HRA Pharma S.A....

...Shreveport, La. Business: Neurology Date completed: 2015-04-10 Type: Venture financing Raised: $2 million Investors: HRA Pharma...

...approval of oral ketoconazole HRA to treat endogenous Cushing's syndrome in patients ages >12 years. HRA Pharma...
...the indication in October 2013 for risks associated with hepatotoxicity, adrenal insufficiency and drug interactions. HRA Pharma S.A....